Form 4: Bespoke Extracts CEO Michael Feinsod Increases Stake in Company

Sentiment:

SEC Form 4


CEO Michael Feinsod reports purchasing additional shares of Bespoke Extracts, Inc. on August 27th and 28th, 2024.

Summary

  • Michael Feinsod, CEO of Bespoke Extracts, Inc., has reported purchasing shares of the company's common stock.
  • On August 27, 2024, Mr. Feinsod acquired 3,000 shares at a price of $0.09 per share.
  • On August 28, 2024, he purchased an additional 2,000 shares, also at $0.09 per share.
  • Following these transactions, Mr. Feinsod directly owns 2,456,112 shares and indirectly owns 1,015,112 shares through Infinity Management, LLC, where he is the managing member.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the CEO's increased investment in the company, which can be interpreted as a sign of confidence. However, the scale of the purchase is relatively small.

Positives

  • The CEO's purchase of additional shares may signal confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued.

Stakeholder Impact

  • Shareholders may view the CEO's purchase as a positive signal.

Key Dates

DateDescription
08/27/2024Michael Feinsod purchased 3,000 shares of Bespoke Extracts at $0.09 per share.
08/28/2024Michael Feinsod purchased 2,000 shares of Bespoke Extracts at $0.09 per share.
08/28/2024Date of signature for the SEC Form 4 filing.

Keywords

Bespoke Extracts, Michael Feinsod, Insider Trading, Share Purchase, Common Stock, Ownership, Infinity Management LLC

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.